- Price is above Fair Value, showing premium demand versus the model.
- Next-week expectancy is positive at 55.74% based on similar historical setup states.
- Activity pressure is constructive, supporting the smart-money activity read.
NGVT
NYSE
Week ended 09 Oct 2026
Weekly Investor Report
Ingevity Corp · Basic Materials · Specialty Chemicals
Latest close
69.76 USD
-3.7%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -3.1% below the Trend Line and sits at 71.5% of its 52-week range. The latest completed week returned -3.7%, after a 0.5% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 45/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: earnings are due in 23d.
Setup score
47
out of 100
Latest Close
69.76 USD
9 Oct 2026
1W Return
-3.7%
latest completed week
4W Return
0.5%
short-term follow-through
12W Return
-8.8%
quarterly tape
Trend Breadth
88.5%
46 of 52 weeks active
Volume Ratio
1.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- 11 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.7%
Latest completed week; four-week move 0.5%.
Indicator stack
49/33
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 55.74%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Bullish
45/100 conviction; expected move 0.0%.
News sentiment
55/100
15 relevant articles in the latest sentiment read.
Event risk
23d
Next report is scheduled for 04 Nov 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -3.1% below the Trend Line and sits at 71.5% of its 52-week range. The latest completed week returned -3.7%, after a 0.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
28 Aug
4 Sep
11 Sep
18 Sep
25 Sep
2 Oct
9 Oct
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5812-week average 0.68
12-week confirmation
Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.58Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1111 reversal markers
No recent accumulation markers. 11 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.5% over four weeks, -8.8% over 12 weeks, and 32.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year46
Trend breadth88.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.88Latest activity-pressure read.
Pressure change-17.7%Four-week change in activity pressure.
Leadership-5.39Latest relative-leadership reading.
RS change-68.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.
Factor week 09 Oct 2026
Financial statements through 30 Jun 2026
Field coverage 91%
Model confidence 89%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength67/100Blend of value, momentum, and quality. Underlying universe rank 34; rank 1 is best.
Value31/100Relative valuation strength. Underlying universe rank 70; rank 1 is best.
Quality92/100Profitability and accounting quality. Underlying universe rank 9; rank 1 is best.
Momentum79/100Medium-term price momentum. Underlying universe rank 22; rank 1 is best.
Growth15/100Revenue and earnings growth. Underlying universe rank 86; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework65/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 44.4x Price divided by trailing earnings.
- Price / sales
- 2.1x Market value relative to trailing revenue.
- EV / EBITDA
- 10.1x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 4.4% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 41.1% Gross profit retained from each unit of revenue.
- Operating margin
- 21.6% Operating profit retained from revenue.
- Free-cash-flow margin
- 13.3% Free cash flow generated from revenue.
- Return on invested capital
- 14.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -12.4% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 3.1% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 5.7% Net share repurchases relative to market value.
- Shareholder yield
- 5.7% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 3.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningBullish
NGVT shows bullish options pressure with a 45/100 conviction score, put-call volume ratio of 0.00, expected move of n/a, and Sharemaestro trend signal inactive.
Conviction45/100
Expected move%
Put/call volume0.00
Insider activity7 / 13
7 acquisitions and 13 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment55/100
Weighted news tone is neutral across 15 relevant articles.
3 positive · 12 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings23dNext report is scheduled for 04 Nov 2026; event risk rises as the date approaches.
Options expected move%Nearest-chain priced movement where available.
52-week drawdown-12.0%Distance below the 52-week high.
13-week volatility4.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
17 Apr
15 May
12 Jun
10 Jul
7 Aug
4 Sep
9 Oct
Weeks higher9 of 2617 weeks finished lower.
Best week+9.1%Week of 12 Jun.
Worst week-10.6%Week of 15 May.
Latest week-3.7%Week of 9 Oct.
Shape of recent returns
Strong gains5
Modest gains4
Flat weeks0
Modest losses13
Sharp losses4
Recent vol4.3%13-week weekly-return volatility.
Base vol5.1%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Basic Materials
4-week rank- / 100
Group average-5.9%
Trend breadth43.0%
Trend43.0%active weekly trend signals
MD49.0%positive activity pressure
RS28.0%positive relative leadership
Four-week leaders
IndustryUS Specialty Chemicals
4-week rank17 / 56
Group average-1.4%
Trend breadth33.9%
Trend33.9%active weekly trend signals
MD25.0%positive activity pressure
RS26.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape47/100
Trend, activity pressure, participation, and risk combine to a 47/100 tape read.
Indicator analysis31/100Latest 12-week confirmation: trend 6/12, activity pressure 0/12, relative leadership 5/12.
Activity pressure 0.58; 11 reversal markers Next-Week ExpectancyPositive 55.74%Next-week expectancy is positive with a 55.74% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors67/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 9; Small Cap Core rank 74 SVQF65/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 367.0 of 1061 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options44/100Call activity leads. Options balance does not yet confirm the saved weekly stock trend.
2026-10-09 · Use with limits · Priced move Unavailable Sentiment55/100Weighted news tone is neutral across 15 relevant articles.
Here's Why You Should Hold Onto Ingevity Stock for Now Insiders7 / 137 acquisitions and 13 disposals in the latest 180-day insider tape.
Earnings23dNext report is scheduled for 04 Nov 2026; event risk rises as the date approaches.
Research flow1 items1 recent research articles and 0 Market Watch posts are available.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 9 Oct 2026 | 69.76 USD | -3.7% | 71.98 USD | 51.93 USD | -0.88 | -5.39 | 1.3M | Off |
| 2 Oct 2026 | 72.41 USD | -0.8% | 71.81 USD | 51.74 USD | -0.91 | -0.50 | 1.3M | Off |
| 25 Sep 2026 | 73.00 USD | 7.0% | 71.56 USD | 51.55 USD | -0.89 | 0.32 | 1.2M | Off |
| 18 Sep 2026 | 68.20 USD | -1.7% | 71.52 USD | 51.39 USD | -0.88 | -4.88 | 1.8M | Off |
| 11 Sep 2026 | 69.41 USD | -1.6% | 71.66 USD | 51.25 USD | -0.75 | -3.21 | 931.0K | Off |
| 4 Sep 2026 | 70.54 USD | 1.6% | 71.90 USD | 51.13 USD | -0.45 | -2.35 | 1.2M | Off |
| 28 Aug 2026 | 69.43 USD | -1.2% | 71.97 USD | 51.00 USD | -0.17 | -3.81 | 1.0M | On |
| 21 Aug 2026 | 70.27 USD | -8.5% | 71.85 USD | 50.90 USD | -0.05 | -2.21 | 1.0M | On |
| 14 Aug 2026 | 76.77 USD | -1.3% | 71.82 USD | 50.78 USD | -0.06 | 5.41 | 1.0M | On |
| 7 Aug 2026 | 77.82 USD | 6.4% | 71.47 USD | 50.62 USD | -0.12 | 7.30 | 1.4M | On |
| 31 Jul 2026 | 73.11 USD | -0.2% | 71.02 USD | 50.46 USD | -0.36 | 4.76 | 1.5M | On |
| 24 Jul 2026 | 73.26 USD | -4.3% | 70.59 USD | 50.37 USD | -0.43 | 6.84 | 978.3K | On |
| 17 Jul 2026 | 76.53 USD | 6.2% | 70.15 USD | 50.30 USD | -0.14 | 11.54 | 1.2M | On |
| 10 Jul 2026 | 72.07 USD | -0.6% | 69.55 USD | 50.21 USD | -0.15 | 4.04 | 1.0M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.